Innate Pharma S.A. (IPHA)

NASDAQ: IPHA · IEX Real-Time Price · USD
2.88
+0.18 (6.67%)
Jul 1, 2022 11:25 AM EDT - Market open

Stock Price Forecast

According to 10 stock analysts, the average 12-month stock price forecast for IPHA stock is $9.5, which predicts an increase of 229.86%. The lowest target is $4.21 and the highest is $14.24. On average, analysts rate IPHA stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $4.21 $9.5 $9.2 $14.24
Change +46.18% +229.86% +219.44% +394.44%

Analyst Ratings

The average analyst rating for IPHA stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 333333
Buy 455555
Hold 222222
Sell 000000
Strong Sell 000000
Total 91010101010

Financial Forecast

Revenue This Year
60.02M
Increased by 142.98%
Revenue Next Year
37.94M
Decreased by -36.79%
EPS This Year
-0.56
EPS Next Year
-0.70
Year 2017201820192020202120222023202420252026
Revenue
44.03M93.95M85.45M69.77M24.70M60.02M37.94M161.06M388.88M948.33M
Revenue Growth
-
113.37%
-9.05%
-18.35%
-64.60%
142.98%
-36.79%
324.52%
141.45%
143.86%
EPS
-0.890.05-0.31-0.81-0.66-0.56-0.700.450.430.41
EPS Growth
--------
-5.53%
-4.58%
No. Analysts -----76411

Revenue Forecast

Revenue 20222023202420252026
High 146.0M 57.8M 425.3M 408.3M 986.3M
Avg 60.0M 37.9M 161.1M 388.9M 948.3M
Low 4.9M 27.9M 21.9M 377.2M 919.9M

Revenue Growth

Revenue Growth 20222023202420252026
High
397.7%
-3.8%
1,020.9%
153.5%
153.6%
Avg
104.7%
-36.8%
324.5%
141.4%
143.9%
Low
-83.3%
-53.5%
-42.4%
134.2%
136.5%

EPS Forecast

EPS 20222023202420252026
High 0.47 -0.59 2.68 0.45 0.43
Avg -0.56 -0.70 0.45 0.43 0.41
Low -1.49 -0.75 -0.60 0.42 0.40

EPS Growth

EPS Growth 20222023202420252026
High - - -
-0.8%
-0.8%
Avg - - -
-5.5%
-4.6%
Low - - -
-8.4%
-7.4%